SMAD4 and cystic neoplasm: Targeted Smad4 inactivation in the mouse pancreas does not initiate tumorigenesis, however concomitant Smad4 loss and KRASG12D expression leads to the rapid development of PanIN lesions and cystic tumors [10-12].